Google’s da­ta-crunch­ing mavens at GV buy in to Deci­bel’s R&D pro­gram for hear­ing loss, tin­ni­tus

GV, bet­ter known as the group once named Google Ven­tures, is buy­ing in­to Boston-based Deci­bel Ther­a­peu­tics. But we don’t know just how much it bought in for.

In a state­ment out Thurs­day morn­ing Deci­bel CEO Steve Holtz­man says GV made an un­spec­i­fied eq­ui­ty in­vest­ment in the com­pa­ny. Just as im­por­tant­ly, the ven­ture group is al­so con­tribut­ing its know-how on an­a­lyz­ing large vol­umes of da­ta, which Deci­bel re­lies on to help steer its de­vel­op­ment work in a still large­ly un­chart­ed ter­ri­to­ry like hear­ing loss and tin­ni­tus.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER